Pioglitazone

Hmm… We’d better think about this again. Pioglitazone is not a good first‑line choice because it causes weight gain and fluid retention and it lacks clear cardiovascular outcome benefits. If a thiazolidinedione is considered at all, it is considered in cases where first line drugs are not indicated or unavailable, or in combination with other first line drugs.

Try to think about other drugs with favourable weight and cardiovascular profiles. Always consider the full clinical context when prescribing medications and try again!

  • I will independently adjust the dose of warfarin (decrease/increase)This is a wrong response that could lead to potentially harmful results to the health [undo]
  • Nurse's Initial Report [undo]
  • Ζητά επαναληπτική εξέταση PCR [undo]
  • Splash! [undo]
  • Λάθος! [undo]
  • Metformin [undo]
  • Insulin [undo]
  • Root Node [undo]
  • No [undo]
  • Aιτία προσέλευσης [undo]
  • Drugs without diagnosis [undo]
  • [undo]
  • I will start taking the blood-clotting pills and the special herb that helps with bleeding gums, my aunt Maria suggested. [undo]
  • Jeg forklarer foreldrene at jeg tar opp saken med assistenten så fort så mulig [undo]
  • IDENTIFICATION OF BIOMOLECULES [undo]
  • Empagliflozin [undo]
  • Ei syödä [undo]
  • new node [undo]
  • Pioglitazone [undo]

Map: Michael Green_GEMD_2 (1116)
Node: 21115
Score:

reset

OpenLabyrinth
OpenLabyrinth is an open source educational pathway system

Review your pathway